Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Berk

Showing results (831-840 of 1,136) with videos related to

Pageof 114
Sort By:
BMC Medicine|December 29, 2018
The SMILES trial: an important first stepFelice N Jacka, Adrienne O'Neil, Catherine Itsiopoulos, et al.
Journal of Affective Disorders|February 28, 2016
Depression is a risk factor for incident coronary heart disease in women: An 18-year longitudinal studyAdrienne O'Neil, Aaron J Fisher, Katherine J Kibbey, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 23, 2020
Adjunctive <i>Garcinia mangostana</i> Linn. (Mangosteen) Pericarp for Schizophrenia: A 24-Week Double-blind, Randomized, Placebo Controlled Efficacy Trial: Péricarpe d'appoint Garcinia mangostana Linn (mangoustan) pour la schizophrénie : un essai d'efficacité de 24 semaines, à double insu, randomisé et contrôlé par placeboAlyna Turner, Andrea Baker, Olivia M Dean, et al.
BMJ Open|March 22, 2020
Minocycline for the treatment of mental health and neurological conditions: study protocol of a systematic review and meta-analysisChiara C Bortolasci, Wolfgang Marx, Adam J Walker, et al.
Journal of Neurophysiology|January 5, 2022
Cocaine increases stimulation-evoked serotonin efflux in the nucleus accumbensJason Yuen, Abhinav Goyal, Aaron E Rusheen, et al.
Psychiatry Research|September 10, 2017
Personality disorder is an excess risk factor for physical multimorbidity among women with mental state disordersShae E Quirk, Amanda L Stuart, Michael Berk, et al.
Frontiers in Neuroscience|February 16, 2023
High frequency deep brain stimulation can mitigate the acute effects of cocaine administration on tonic dopamine levels in the rat nucleus accumbensJason Yuen, Abhinav Goyal, Aaron E Rusheen, et al.
Acta Psychiatrica Scandinavica|July 13, 2024
Efficacy and tolerability of monoamine oxidase inhibitors for the treatment of depressive episodes in mood disorders: A systematic review and network meta-analysisAnna Giménez-Palomo, Anjli K Chamdal, Natalie Gottlieb, et al.
The Australian and New Zealand Journal of Psychiatry|November 22, 2015
Medical burden, body mass index and the outcome of psychosocial interventions for bipolar depressionAmy T Peters, Leah W Shesler, Louisa Sylvia, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 23, 2016
Affective instability and the course of bipolar depression: results from the STEP-BD randomised controlled trial of psychosocial treatmentJonathan P Stange, Louisa G Sylvia, Pedro Vieira da Silva Magalhães, et al.
Pageof 114

Showing results (831-840 of 1,136) with videos related to

Sort By:
Pageof 114
BMC Medicine|December 29, 2018
The SMILES trial: an important first stepFelice N Jacka, Adrienne O'Neil, Catherine Itsiopoulos, et al.
Journal of Affective Disorders|February 28, 2016
Depression is a risk factor for incident coronary heart disease in women: An 18-year longitudinal studyAdrienne O'Neil, Aaron J Fisher, Katherine J Kibbey, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 23, 2020
Adjunctive <i>Garcinia mangostana</i> Linn. (Mangosteen) Pericarp for Schizophrenia: A 24-Week Double-blind, Randomized, Placebo Controlled Efficacy Trial: Péricarpe d'appoint Garcinia mangostana Linn (mangoustan) pour la schizophrénie : un essai d'efficacité de 24 semaines, à double insu, randomisé et contrôlé par placeboAlyna Turner, Andrea Baker, Olivia M Dean, et al.
BMJ Open|March 22, 2020
Minocycline for the treatment of mental health and neurological conditions: study protocol of a systematic review and meta-analysisChiara C Bortolasci, Wolfgang Marx, Adam J Walker, et al.
Journal of Neurophysiology|January 5, 2022
Cocaine increases stimulation-evoked serotonin efflux in the nucleus accumbensJason Yuen, Abhinav Goyal, Aaron E Rusheen, et al.
Psychiatry Research|September 10, 2017
Personality disorder is an excess risk factor for physical multimorbidity among women with mental state disordersShae E Quirk, Amanda L Stuart, Michael Berk, et al.
Frontiers in Neuroscience|February 16, 2023
High frequency deep brain stimulation can mitigate the acute effects of cocaine administration on tonic dopamine levels in the rat nucleus accumbensJason Yuen, Abhinav Goyal, Aaron E Rusheen, et al.
Acta Psychiatrica Scandinavica|July 13, 2024
Efficacy and tolerability of monoamine oxidase inhibitors for the treatment of depressive episodes in mood disorders: A systematic review and network meta-analysisAnna Giménez-Palomo, Anjli K Chamdal, Natalie Gottlieb, et al.
The Australian and New Zealand Journal of Psychiatry|November 22, 2015
Medical burden, body mass index and the outcome of psychosocial interventions for bipolar depressionAmy T Peters, Leah W Shesler, Louisa Sylvia, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 23, 2016
Affective instability and the course of bipolar depression: results from the STEP-BD randomised controlled trial of psychosocial treatmentJonathan P Stange, Louisa G Sylvia, Pedro Vieira da Silva Magalhães, et al.
Pageof 114